The ethanol fraction from the stem of Berberis libanotica inhibits the viability of adult T cell leukemia

被引:0
|
作者
Esseily, F. [1 ]
El Ezzy, M. [2 ]
Gali-Muhtasib, H. [3 ]
Safi, S. [5 ]
Esseily, J. [5 ]
Diab-Assaf, M. [5 ]
Lampronti, I. [4 ]
Saab, A. [4 ]
机构
[1] Lebanese Univ, Fac Publ Hlth, Sect 2, Lab Sci Dept, Jdeidet El Metn, Lebanon
[2] Lebanese Univ, Fac Sci 1, Dept Biol, Jdeidet El Metn, Lebanon
[3] Amer Univ Beirut, Dept Biol, Beirut, Lebanon
[4] Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy
[5] Lebanese Univ, Fac Sci 2, Dept Biol, Jdeidet El Metn, Lebanon
关键词
Plants; medicinal; Antineoplastic agents; Ethanol; Leukemia-lymphoma; adult T-cell; APOPTOSIS; HTLV-1; PLANTS;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aim. In the Mediterranean countries, several described medicinal plants are derived from Lebanon. According to Tohme et al. there are 2597 species in Lebanon. More than fifty two percent are endemic to Lebanon. In this paper we show that the ethanol fraction of the stem of Berberis libanotica is able to inhibit the viability of HTLV-1 positive (HuT-102) and HTLV-1 negative (CEM) cell lines of malignant T-cell leukemia. Methods. After traditional maceration to extract the ethanol fraction from Berberis libanotica stem, the in vitro viability was assayed. Results. The results suggest that Berberis libanotica (a Lebanese medicinal plant) contains a substantial amount of secondary metabolites such as alkaloids powerful in inhibiting the viability of HuT-102 and CEM cell lines. Conclusion. The obtained results demonstrate a novel anticancer property of Berberis libanotica stem extracts, in addition to the previously reported anti-inflammatory activity.
引用
收藏
页码:129 / 133
页数:5
相关论文
共 50 条
  • [31] Treatment of Adult T-cell Leukemia
    Uozumi, Kimiharu
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2010, 50 (01) : 9 - 25
  • [32] Adult T-cell leukemia in Japan
    Takatsuki, K
    Matsuoka, M
    Yamaguchi, K
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 : S15 - S19
  • [33] Adult T-Cell Leukemia/Lymphoma
    Qayyum, Sohail
    Choi, John K.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2014, 138 (02) : 282 - 286
  • [34] Treatment for adult T-cell leukemia
    Hanada, S
    Utsunomiya, A
    Suzuki, S
    Uozumi, K
    Makino, T
    Arima, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (Suppl 1) : S47 - S50
  • [35] Discovery of adult T-cell leukemia
    Takatsuki, K
    RETROVIROLOGY, 2005, 2 (1)
  • [36] Leukemogenesis of adult T-cell leukemia
    Yasunaga, JI
    Matsuoka, M
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (04) : 312 - 320
  • [37] ADULT T-CELL LEUKEMIA LYMPHOMA
    PEREIRA, J
    LIRA, P
    GREBE, G
    ROA, I
    REVISTA MEDICA DE CHILE, 1985, 113 (01) : 41 - 44
  • [38] ADULT T-CELL LEUKEMIA LYMPHOMA
    KUEFLER, PR
    BUNN, PA
    CLINICS IN HAEMATOLOGY, 1986, 15 (03): : 695 - 726
  • [39] Treatment for adult T-cell leukemia
    S. Hanada
    Atae Utsunomiya
    Shinsuke Suzuki
    Kimiharu Uozumi
    Torahiko Makino
    Terukatsu Arima
    Cancer Chemotherapy and Pharmacology, 1997, 40 : S47 - S50
  • [40] Adult T cell leukemia-lymphoma
    Riyaz, Najeeba
    Latheef, Ettappurath N. Abdul
    Sasidharanpillai, Sarita
    Rahima, Saleem
    Bindu, Valiaveetil
    Nermin, Ahmedali
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2014, 80 (04): : 358 - +